Begley, Jonathan

Immunosensitization with a Bcl-2 small molecule inhibitor. [electronic resource] - Cancer immunology, immunotherapy : CII May 2009 - 699-708 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1432-0851

10.1007/s00262-008-0592-4 doi


Animals
Antigens, Neoplasm--immunology
Apoptosis--drug effects
Biphenyl Compounds--therapeutic use
Cancer Vaccines--immunology
Cell Line, Tumor--drug effects
Colonic Neoplasms--immunology
Cytotoxicity, Immunologic
Dendritic Cells--immunology
Drug Screening Assays, Antitumor
Humans
Immunotherapy--methods
Immunotherapy, Adoptive
Intramolecular Oxidoreductases--genetics
Killer Cells, Lymphokine-Activated--transplantation
Listeria monocytogenes--immunology
Melanoma, Experimental--immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasm Proteins--antagonists & inhibitors
Nitrophenols--therapeutic use
Piperazines--therapeutic use
Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors
Receptors, Death Domain--agonists
Recombinant Fusion Proteins--immunology
Sulfonamides--therapeutic use
TNF-Related Apoptosis-Inducing Ligand--pharmacology
Tumor Necrosis Factor-alpha--pharmacology
fas Receptor--pharmacology